Local anaesthetic creams
Preparations effective on skin should increase use Local anaesthetic creams are generally ineffective when applied to intact human skin because they are poorly absorbed.' This has limited their use to topical anaesthesia of mucous membranes. To diffuse through nerve membranes the local anaesthetic must be in the form of the unchanged base, but formulations in which the lipid soluble free base dissolves easily achieve poor penetration of unbroken skin. This problem seems now to have been overcome with a eutectic ("melting readily") combination of lignocaine and prilocaine.2 When mixed together at room temperature crystals of these drugs form an oily liquid. No additional solvent is necessary, so droplets of an oil in water emulsion of lignocaine and prilocaine each have a concentration of 80% of active drug compared with the 20% of conventional formulations. The total concentration of local anaesthetic remains low at 5%. The cream is applied under an occlusive plastic dressing.
Lignocaine-prilocaine cream produces effective topical dermal anaesthesia in both children and adults. In placebo controlled studies it reduced significantly the pain of venepuncture or venous cannulation.3-7 A disadvantage is that the cream must usually be applied for 60 minutes to be effective,' though in children aged 1-5 years 30 minutes seems to be sufficient.9 Topical anaesthesia persists for at least one hour after removing the cream.
The advantages of avoiding painful needle punctures, particularly in children, are selfevident. Not only is subjective discomfort reduced but also the procedure is easier to carry out. Routines in wards and operating rooms may usually be easily arranged to accommodate the minimum application time.
Few local adverse reactions have been reported, although blanching of the skin'0 (which may persist after removing the cream), erythema, and mild local oedema may occur. Irritation and itching have not been a problem," 12 and no delayed hypersensitivity or other allergic reactions have been recorded.
Systemic absorption of lignocaine and prilocaine from this formulation seems to be minimal when applied to intact skin," but there are no data concerning use on mucous membranes. Topical anaesthesia of mucous membranes may be achieved with lignocaine-prilocaine cream after a few minutes, but the formulation is not recommended for such use until more information is available. There has been one report of methaemoglobinaemia in a 12 week old infant who had had extensive treatment with the cream on the skin over several hours and had also been receiving trimethoprim and sulphamethoxazole for over two months.'3 Prilocaine and sulphonamides are known to cause the formation of methaemoglobin and may in this case have had an additive effect. Using the cream in older infants is not associated with important increases in methaemoglobin concentration. 14 Lignocaine-prilocaine cream has been successfully used before lumbar puncture in both adults'5 and children,'6 for various dermatological procedures,'2 and before split skin grafting.'7 Normally for these procedures infiltration with local anaesthetic would be used but this is painful and may obliterate anatomical landmarks, making the procedure more difficult. The availability of an effective transdermal preparation of local anaesthetic means that other less obvious indications may be explored. The exquisite hyperaesthesia that may occur with postherpetic neuralgia is extremely difficult to treat but may respond, albeit temporarily, to infiltration with a local anaesthetic and corticosteroid. Trials of lignocaineprilocaine cream are currently under way for this condition, and initial experience indicates that some patients may obtain considerable benefit (C Glynn, unpublished data). 
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Veterinary medicines in animal foods
Reassuringfindings but surveillance should go on Consumers' organisations have become anxious about intentional and unintentional food additives, among which may be residues of drugs given to animals reared for food. There is less concern about antimicrobial drugs given occasionally to an animal with an acute infection than about the use of anabolic hormones to increase the efficiency of meat production. If the hormones carry over into the meat or milk in adequate amounts they might cause effects or chronic toxicity.
Veterinary surgeons now have less freedom in prescribing for farm animals than doctors have for humans. Many drugs are banned, and others can be given only to some animals by specified routes, with a defined withdrawal period before slaughter or taking milk or eggs for consumption. Farmers have to follow the written veterinary instructions or in some cases they may be liable to prosecution. They are also having to follow not only the code of practice of the Ministry of Agriculture, Fisheries, and Food but, increasingly, the directives of the European Community. Thus chloramphenicol is licensed for only restricted veterinary uses. Diethylstilboestrol and the related stilbene oestrogens that had been used as growth promoters were prohibited in Britain in 1982 in harmony with the European Community. Diethylstilboestrol is a known carcinogen, orally active and persistent. The European Community went further in 1986, banning the use of all hormone growth promoters, against the advice of its own scientific group, which had evidence that properly used natural hormones such as testosterone or progesterone produce unimportant residues in meat and are no risk to health.' The United Kingdom has had to follow suit.
Nevertheless, making regulations is useless unless they can be enforced. Specialised analysts in Britain and elsewhere have developed specific and sensitive methods for detecting residues of veterinary medicines in food. Typically these methods are radioimmunoassay or high performance liquid chromatography. Controlled animal trials have to be done to see which organ(s) concentrate(s) the residues, which metabolites are formed, and how long the drug and its metabolites persist after the usual dosage. Choices have to be made between random sampling of the main abattoirs in proportion to their throughput and sampling tissues from special subgroups of animals that seem particularly likely to have been given the drugs. Choices have also to be made between home produced and imported meat.
The working party on veterinary residues in animal products of the Ministry of Agriculture, Fisheries, and Food.has reported the results of analyses carried out between 1979 and 1985 on animal products. These looked for residues of the three major groups of agents used in veterinary medicinesanabolic, anthelmintic, and antimicrobial compounds.2 The proportion of samples containing diethylstilboestrol was 8% in 1981, the year before it was banned; it has since fallen to 0 3%. In six cases illegal use was suspected (in calves or pigs), and in two of these the persons responsible were prosecuted and fined. Minute amounts ofa different and apparently safer anabolic agent, zeranol, were found in some beef samples during 1983-4. This drug was prohibited in 1986 but surveillance will be continued as a precaution. In 1981 samples of fat from male calves and samples ofplasma from female calves were analysed for progesterone and testosterone, respectively: the concentrations of both were inside the normal range in all samples.
The anthelmintic compounds looked for were levamisole and five benzimidazole compounds (such as thiabendazole and mebendazole). No residues were found in either liver or meat-a reassuring result because levamisole may cause agranulocytosis in man. Samples ofmilk will now be analysed in a similar way.
A non-specific bacteriological test for antimicrobial activity gave positive results in about 1% of animals between 1980 and 1983, particularly in kidneys from cattle and pigs. Sulphadimidine was detected chemically in a fifth of the pigs' kidneys, halfofwhich had concentrations above the maximum acceptable value of 0 1 mg/kg. The Ministry of Agriculture, Fisheries, and Food has informed pig farmers of the results and of the need to observe withdrawal periods. No chloramphenicol or furazolidone was detected in kidneys from quadrupeds or farmed trout, respectively. Oxytetracycline was found in some samples of farmed trout at concentrations averaging 0'2 mg/kg. Such concentrations are unlikely to have any toxicological consequences, though there is still a possibility of inducing bacterial resistance to antibiotics. The working party is now developing similar chemical methods for residues of aminoglycosides, penicillins, and cephalosporins.
These findings should reassure the public about this aspect of the safety of foodstuffs derived from animals. The British system of surveillance entails hard work for several ministerial committees, abattoirs throughout the country, seven analytical laboratories, the veterinary profession, and farmers' organisations. All this costs money, but it is clearly important that surveillance should carry on.
